EMD-35029
SARS-CoV2 spike protein with ACE2, no ACE2 binding.
EMD-35029
Single-particle3.3 Å
Deposition: 23/12/2022Map released: 27/12/2023
Last modified: 27/12/2023
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV2 spike protein with ACE2, no ACE2 binding, 1 RBD in up form
Deposition Authors: Kishikawa J, Hirose M
,
Kato T ,
Okamoto T
Sample: SARS-CoV2 spike protein with ACE2, no ACE2 binding, 1 RBD in up form
Deposition Authors: Kishikawa J, Hirose M
,
Kato T ,
Okamoto T
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models.
Urano E ,
Itoh Y ,
Suzuki T,
Sasaki T ,
Kishikawa JI ,
Akamatsu K ,
Higuchi Y ,
Sakai Y ,
Okamura T,
Mitoma S ,
Sugihara F,
Takada A,
Kimura M,
Nakao S,
Hirose M ,
Sasaki T ,
Koketsu R,
Tsuji S ,
Yanagida S,
Shioda T ,
Hara E ,
Matoba S ,
Matsuura Y ,
Kanda Y ,
Arase H ,
Okada M ,
Takagi J ,
Kato T ,
Hoshino A ,
Yasutomi Y ,
Saito A ,
Okamoto T
(2023) Sci Transl Med , 15 , eadi2623 - eadi2623
,
Itoh Y ,
Suzuki T,
Sasaki T ,
Kishikawa JI ,
Akamatsu K ,
Higuchi Y ,
Sakai Y ,
Okamura T,
Mitoma S ,
Sugihara F,
Takada A,
Kimura M,
Nakao S,
Hirose M ,
Sasaki T ,
Koketsu R,
Tsuji S ,
Yanagida S,
Shioda T ,
Hara E ,
Matoba S ,
Matsuura Y ,
Kanda Y ,
Arase H ,
Okada M ,
Takagi J ,
Kato T ,
Hoshino A ,
Yasutomi Y ,
Saito A ,
Okamoto T
(2023) Sci Transl Med , 15 , eadi2623 - eadi2623